Original Article
Brief Report
Role of COL4A1 in Small-Vessel Disease and Hemorrhagic Stroke
N Engl J Med 2006; 354:1489-1496April 6, 2006
- Abstract
Small-vessel diseases of the brain underlie 20 to 30 percent of ischemic strokes and a larger proportion of intracerebral hemorrhages. In this report, we show that a mutation in the mouse Col4a1 gene, encoding procollagen type IV α1, predisposes both newborn and adult mice to intracerebral hemorrhage. Surgical delivery of mutant mice alleviated birth-associated trauma and hemorrhage. We identified a COL4A1 mutation in a human family with small-vessel disease. We concluded that mutation of COL4A1 may cause a spectrum of cerebrovascular phenotypes and that persons with COL4A1 mutations may be predisposed to hemorrhage, especially after environmental stress.
Media in This Article
Figure 1
Hemorrhagic Phenotypes in Mutant Mice.Figure 2
Abnormalities of the Retinal and Renal Vasculature.Article Activity
- Article
Stroke is a leading cause of death and serious long-term disability in developed nations.1 Survivors often have a severely diminished quality of life, require long-term care, and are at high risk for recurrence.1 Intracerebral hemorrhage accounts for 10 to 15 percent of strokes and is a particularly severe form of stroke, with disproportionately high rates of death and long-term disability.1 Hypertension and amyloid angiopathy are important risk factors associated with intracerebral hemorrhage; other risk factors include vascular malformations, coagulation abnormalities, and the use of sympathomimetic drugs.2 However, intracerebral hemorrhage often occurs in the absence of a history of known risk factors, indicating that other, unidentified, predisposing factors are present in many patients. Small-penetrating-vessel diseases underlie up to 30 percent of ischemic strokes and a larger proportion of intracerebral hemorrhages. Despite extensive investigation, the causes of small-vessel disease or intracerebral hemorrhage are usually unknown, particularly in younger patients.
We recently identified mutations in a gene encoding type IV collagen α1 (COL4A1), a basement-membrane protein, in mice and in human families with porencephaly.3,4 Porencephaly developed in less than 20 percent of Col4a1-mutant mice. Because all the mutant mice were genetically identical, porencephaly in this model may be caused by an interaction between the mutation and the environment. We proposed that pressure on the head during birth induces hemorrhage and that the degree of pressure insult could determine whether porencephaly ensues. We further hypothesized that mutated Col4a1 or COL4A1 could predispose adult mice and people who do not have porencephaly to vascular disease.
In the current investigation, we tested our hypothesis that environmental stress and Col4a1 mutation conspire to induce hemorrhage. We also investigated the broader medical importance of COL4A1 in the pathogenesis of hemorrhagic stroke in adults.
Methods
Animals
Experiments were conducted in compliance with the guidelines of the institutional animal care and use committee guidelines. Unless otherwise stated, all mice used in experiments were backcrossed a minimum of eight generations to C57BL/6J mice and were matched according to age and strain. To produce CASTB6F1 mice, mutant mice were backcrossed six generations to inbred C57BL/6J mice and the offspring were then crossed to inbred CAST/EiJ mice.
Surgical Delivery
Sperm from four mutant mice was used for in vitro fertilization of oocytes from C57BL/6J female mice, and embryos were then transferred into FVB/NJ female mice. Thirteen female mice gave birth normally, yielding a cohort of control mice. Pups were delivered by hysterectomy in the case of 16 female mice. Each litter was housed with a single foster mother.
Adult Survival
The age at death was defined in two-month intervals, with the survival percentage calculated by dividing the number of mice that died at a particular age by the total number of mice in the aging experiment. Because mice were removed for various experiments, the total numbers of mice in successively older age groups decreased. The respective total numbers of control and mutant mice retained in each age group were as follows: 2 to 3.9 months, 1026 and 320; 4 to 5.9 months, 640 and 280; 6 to 7.9 months, 131 and 162; 8 to 9.9 months, 107 and 126; 10 to 11.9 months, 105 and 110; 12 to 13.9 months, 92 and 90; 14 to 15.9 months, 65 and 57; 16 to 17.9 months, 47 and 41; 18 to 19.9 months, 35 and 34; and 20 to 27.9 months, 19 and 18.
Histology
For histologic examination of the lungs, the intact trunk was placed in Bouin's fixative at 4°C overnight. Five-micron sections of paraffin-embedded tissues were stained with hematoxylin and eosin. For histologic examination of brain tissue, deeply anesthetized mice (four to five months old) were transcardially perfused with phosphate-buffered saline, followed by either 4 percent paraformaldehyde or a combination of 0.8 percent paraformaldehyde and 1.2 percent glutaraldehyde in 0.1 M phosphate buffer. Two-millimeter coronal brain slices were examined for gross evidence of intracerebral hemorrhage before being embedded in paraffin and sectioned. Electron microscopy was performed as described previously.3
Clinical Measurements
Fluorescein angiography5 and blood-pressure measurement6 were performed as described previously. Urine was analyzed with use of a Synchron CX clinical analyzer (Beckman Coulter), according to the manufacturer's protocol.
Analysis of Mutations in Patients
A detailed clinical report describing a French family has been published previously.7 Permission for the study was granted by the institutional review board after written informed consent had been obtained from the patients. Sequence analysis was performed as described previously.3 Ninety-eight ethnically and geographically matched persons served as controls and were also evaluated for the presence of mutations by direct sequence analysis.
Results
Interaction of Trauma and Mutation as a Cause of Cerebral Hemorrhage
All heterozygous (Col4a1+/Δex40 ) mutant pups have cerebral hemorrhage, and approximately 50 percent die on the day of birth.3 Thus, the Col4a1 mutation may predispose mice to vascular fragility and act in concert with birth trauma to cause cerebral hemorrhage. To test this possibility, we compared the presence or absence and degree of hemorrhage in pups born naturally with those observed in pups delivered surgically. All naturally born mutant pups had obvious hemorrhages, which were considered severe in most cases (14 of 20) (Figure 1AFigure 1
Hemorrhagic Phenotypes in Mutant Mice.). In contrast, surgical delivery of mutant pups had a profound effect (Figure 1B): none of 26 surgically delivered mutant pups had severe hemorrhage (P<0.001 by the chi-square test). This finding indicates that Col4a1 mutations can weaken vessels and confer substantially increased susceptibility to stress-induced hemorrhage.Respiratory Defects in Mutant Mice
Although surgical delivery prevented cerebral hemorrhage, it did not prevent perinatal death. Unexpectedly, the viability of surgically delivered mutant pups was less than that of mutant pups born naturally (see the Supplementary Appendix, available with the full text of this article at www.nejm.org). Newborn mutant pups were often cyanotic and in respiratory distress. As compared with wild-type pups, which had expanded lungs and open alveoli, the mutant pups had compact lungs, with few or no terminal air spaces visible (see Figure S1 of the Supplementary Appendix). This finding suggests that respiratory defects contribute to perinatal mortality.
Cerebral Hemorrhage Due to COL4A1 Mutation in Adult Mice
In addition to perinatal effects, adult mutant mice may have weakened vasculature that predisposes them to later-onset cerebral hemorrhage. To evaluate this possibility, we allowed the mice to age and found that the rate of death was higher among the mutant mice than among their control littermates (Figure 1C). Some adult mutant mice had sudden overt neurologic deficits, including seizures and hemiparesis. On examination, these mice, but not control mice, often had subarachnoid hemorrhage (Figure 1E). We therefore concluded that Col4a1 mutation predisposes adult mice to hemorrhagic stroke.
The frequency of hemorrhagic episodes in these mice may be greater than the frequency of clinical manifestations of stroke. To identify clinically silent intracerebral hemorrhage, we examined the brains of mice with no obvious neurologic abnormalities. All the mutant mice, but none of the wild-type mice, had intracerebral hemorrhage (Figure 1F through 1K). At three months of age (at which time intracerebral hemorrhage was observed in the mutant mice), mutant and wild-type mice had virtually identical blood pressures and heart rates (Figure S2 of the Supplementary Appendix). Our data indicate that mutant vessels are weak enough to rupture, even in the absence of hypertension.
Predominance of Recurrent Adult Hemorrhage in the Basal Ganglia
The presence of hemorrhages at different stages of repair clearly indicates that mutant mice are predisposed to spontaneous, multifocal cerebral hemorrhage as adults. In some cases, mice had multiple fresh hemorrhages (Figure 1H), some of which were probably induced by artificially elevated intravascular pressure during perfusion before the tissue was harvested. The spontaneous cerebral hemorrhages tended to occur in specific locations. Hemosiderin was almost always observed in the basal ganglia in adult mice (Figure 1G, 1H, 1J, and 1K). Of the 23 lesions with hemosiderin or fibrosis that were identified, 22 were in the basal ganglia and only 1 was in the cortex.
Vascular Defects at Sites Other Than the Brain
In addition to having multifocal recurrent hemorrhage, mutant mice had other phenotypes that occur in some families with small-vessel disease.7-9 These phenotypes include retinal vascular tortuosity, defects in the glomerular basement membrane, and microalbuminuria (Figure 2Figure 2
Abnormalities of the Retinal and Renal Vasculature., and the Supplementary Appendix). Vascular tortuosity was evident solely in mice with the C57BL/6J genetic background (Figure 2, and the Supplementary Appendix).Small-Vessel Disease Due to COL4A1 Mutations in Mice and Humans
The phenotypic similarities between Col4a1-mutant mice and a French family with small-vessel disease (Figure 3AFigure 3
COL4A1 Mutation in a Family with Retinal Arteriolar Tortuosity, White-Matter Abnormalities, and Cerebral Hemorrhage.) prompted us to assess the family for COL4A1 mutations. All six affected members of this family had retinal arteriolar tortuosity (Figure 3B), including one member with retinal hemorrhage. In addition, two of the genotypically affected persons had infantile hemiparesis, and three had migraine with aura. Neuroimaging showed diffuse leukoencephalopathy associated with dilated perivascular spaces in all the affected family members (Figure 3C). Microbleeds in several areas were observed on magnetic resonance imaging (MRI) of the brain (Figure 3D), suggesting involvement of the cerebral vasculature in this family. Two members of the family had a fatal intracerebral hemorrhage. One died after cerebral trauma, and a second had a fatal intracerebral hemorrhage while receiving anticoagulant therapy.Sequence analysis revealed a G1769A transition in exon 25 of COL4A1 that segregated with the disease and that was not observed in 196 chromosomes from unaffected French persons (Figure 3E). The mutation changed the glycine residue at position 562 to glutamic acid (G562E) within the triple-helix domain of the protein. Glycine residues are highly conserved within the triple-helix domain of collagen type IV α1, and mutations in codons encoding glycine are pathogenic in multiple species.3,4,10
Discussion
We have shown that a semidominant mutation in the mouse Col4a1 gene confers a genetic predisposition to environmental-stress–induced hemorrhage and adult-onset stroke. Furthermore, this genetic predisposition extends beyond hemorrhagic stroke to include retinal and renal vascular defects and white-matter abnormalities. In both humans and mice, there was considerable phenotypic variability; intracerebral hemorrhages ranged from being clinically silent to fatal. Our data suggest that this form of hemorrhagic stroke reflects a strong gene–environment interaction.
Compromised cerebral vasculature in Col4a1 mutants leads to hemorrhagic stroke, especially in the context of trauma. Birth trauma is a major factor contributing to perinatal hemorrhage in mice with mutations in Col4a1. By alleviating this trauma, hemorrhage was dramatically reduced. The risk did not end at birth, however: adult mice also had cerebral hemorrhage. Consistent with this observation was the death from hemorrhage after accidental head trauma of a person with a COL4A1 mutation. These data suggest that in persons with COL4A1 mutations, trauma at birth and during adulthood is a stronger risk factor for intracerebral hemorrhage than it is in persons without these mutations. Persons with such mutations are probably sensitized to other risk factors for cerebral hemorrhage, such as hypertension or exercise-induced stress. A second member of the family described in this report had a fatal cerebral hemorrhage while receiving anticoagulant medication, suggesting that anticoagulant use exacerbates the risk associated with COL4A1 mutations.
The phenotype resulting from mutated Col4a1 varies among mice with different genetic backgrounds. Similarly, affected patients in the family described here had retinal vascular tortuosity, whereas previously described families with COL4A1 mutations did not.3,4 Some members of families with porencephaly have only hemorrhagic stroke,11 and some patients known to have COL4A1 mutations have only white-matter abnormalities on MRI.7,11 These data suggest that any of the phenotypes we have observed could be present as isolated features in a family or an individual patient. The specific phenotype in any single patient probably depends on a combination of factors, including the specific mutant allele, other genetic interactions, and environmental influences.
The location of intracerebral hemorrhage (namely, in the region of small penetrating vessels that supply the basal ganglia) in mutant mice is coincident with that in approximately 75 percent of patients with intracerebral hemorrhage. Thus, unlike other forms of hemorrhagic stroke that are caused by mutation of a single gene (cerebral amyloid angiopathy or cerebral cavernous malformations), intracerebral hemorrhage caused by a Col4a1 mutation is reminiscent of intracerebral hemorrhage in small-penetrating-vessel disease. The presence of a collagen type IV α1 mutation compromises the vascular basement membrane and weakens the vessel. Without neuropathological material showing that hemorrhages in our patients arise from these small vessels or that the vessels give rise to the microaneurysms that characterize typical hypertensive hemorrhages, we cannot judge the extent of similarity between the vascular changes due to COL4A1 mutations and those that arise spontaneously or with hypertension. Nonetheless, we hypothesize that the changes in the basement membrane caused by the mutations may explain the predominance of lesions in the basal ganglia. Microvasculature devoid of supporting cells and branching at large angles would be highly susceptible to hemorrhage. Lenticulostriate vessels, small penetrating vessels that supply the basal ganglia and branch off their parent vessels at right angles, creating a point of increased stress, meet the susceptibility criteria. The majority of hemorrhages in humans appear to involve the lenticulostriate vessels. Taken together, the location of hemorrhages in the basal ganglia and the identification of COL4A1 mutations in patients with intracerebral hemorrhage in the absence of other defects provide support for the need for an evaluation of COL4A1 alleles as risk factors for cerebral small-vessel disease and intracerebral hemorrhage in humans.
As multifactorial diseases, small-vessel diseases and intracerebral hemorrhage are expected to have genetic contributions from multiple genes. On the basis of our results with COL4A1, we propose that alleles of other basement membrane genes, such as those encoding the other collagens, the laminins, nidogen, and perlecan, could also genetically predispose persons to small-vessel disease and intracerebral hemorrhage. Our data support the possibility that LAMB2 may underlie hereditary endotheliopathy, retinopathy, nephropathy, and stroke with linkage to chromosome 3p21.12 Our findings suggest that prevention of birth trauma (cesarean delivery) and adult trauma and avoidance of risk factors for bleeding may decrease the risk of hemorrhagic stroke in patients with mutated COL4A1.
Supported by a fellowship from the Focus on Stroke Program of the Canadian Stroke Network (to Dr. Gould), by the Centre for Medical Systems Biology in the Netherlands (Dr. Heutink), a grant (DK064687) from the National Institutes of Health, an Established Investigator Award from the American Heart Association (to Dr. Miner), and a grant (EY117211) from the National Institutes of Health (to Dr. John). Scientific services were subsidized by a grant (CA34196) from the National Institutes of Health. Dr. John is an Investigator of the Howard Hughes Medical Institute.
No potential conflict of interest relevant to this article was reported.
We are indebted to the family for their participation; to M. Boukobza for providing the brain imaging; to J. Maciazek, M. Arnoult, and A. Blécon for their help in genotyping the patients; to R. Bronson, R. Libby, B. Brunken, and R. Smith for helpful discussions; to R. Burgess, G. Cox, T. Gridley, and J. Marchant for critical review of the manuscript; to J. Kulik, R. Taft, and the Jackson Laboratory Reproductive Services for assistance with hysterectomy experiments; and to J. Torrance for work on the figures.
Source Information
From the Howard Hughes Medical Institute (D.B.G., F.C.P., S.W.M.J.) and the Jackson Laboratory (D.B.G., F.C.P., J.P.S., S.W.M.J.) — both in Bar Harbor, Me.; the Department of Human Genetics, Section of Medical Genomics, VU University Medical Center, and the Center for Neurogenomics and Cognitive Research, VU University and VU University Medical Center, Amsterdam (S.E.M., P.H.); Service de Neurologie (K.V., M.G.B.) and Service d'Ophtalmologie (P.M.), Assistance Publique des Hôpitaux de Paris, Hôpital Lariboisière, Paris; INSERM Unité 740 and Laboratoire de Génétique, Assistance Publique des Hôpitaux de Paris, Paris (M.G.B., E.T.-L.); the Renal Division, Washington University School of Medicine, St. Louis (J.H.M.); and the Department of Ophthalmology, Tufts University School of Medicine, Boston (S.W.M.J.).
Address reprint requests to Dr. John at the Jackson Laboratory, 600 Main St., Bar Harbor, ME 04609, or at swmj@jax.org.
- References
References
1
Heart disease and stroke statistics — 2005 update. Dallas: American Heart Association, 2005.
2
Kase CS, Mohr JP, Caplan LR. Intracerebral hemorrhage. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. Stroke: pathophysiology, diagnosis, and management. 3rd ed. Philadelphia: W.B. Saunders, 1998:649-700.
3
Gould DB ,Phalan FC ,Breedveld GJ , et al. Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science 2005;308:1167-1171
CrossRef | Web of Science | Medline4
Breedveld G, de Coo RF, Lequin MH, et al. Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly. J Med Genet (in press).
5
Hawes NL ,Smith RS ,Chang B ,Davisson M ,Heckenlively JR ,John SW . Mouse fundus photography and angiography: a catalogue of normal and mutant phenotypes. Mol Vis 1999;5:22-22
Medline6
Sugiyama F ,Churchill GA ,Li R , et al. QTL associated with blood pressure, heart rate, and heart weight in CBA/CaJ and BALB/cJ mice. Physiol Genomics 2002;10:5-12
Web of Science | Medline7
Vahedi K ,Massin P ,Guichard JP , et al. Hereditary infantile hemiparesis, retinal arteriolar tortuosity, and leukoencephalopathy. Neurology 2003;60:57-63
Web of Science | Medline8
Jen J ,Cohen AH ,Yue Q , et al. Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology 1997;49:1322-1330
Web of Science | Medline9
Plaisier E ,Alamowitch S ,Gribouval O , et al. Autosomal-dominant familial hematuria with retinal arteriolar tortuosity and contractures: a novel syndrome. Kidney Int 2005;67:2354-2360
CrossRef | Web of Science | Medline10
Gupta MC ,Graham PL ,Kramer JM . Characterization of alpha1(IV) collagen mutations in Caenorhabditis elegans and the effects of alpha1 and alpha2(IV) mutations on type IV collagen distribution. J Cell Biol 1997;137:1185-1196
CrossRef | Web of Science | Medline11
Mancini GM ,de Coo IF ,Lequin MH ,Arts WF . Hereditary porencephaly: clinical and MRI findings in two Dutch families. Eur J Paediatr Neurol 2004;8:45-54
CrossRef | Web of Science | Medline12
Ophoff RA ,DeYoung J ,Service SK , et al. Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3. Am J Hum Genet 2001;69:447-453
CrossRef | Web of Science | Medline
- Citing Articles (64)
Citing Articles
1
Tobias Kurth, Hugues Chabriat, Marie-Germaine Bousser. (2012) Migraine and stroke: a complex association with clinical implications. The Lancet Neurology 11:1, 92-100
CrossRef2
SIDDHARTH SHAH, SIAN ELLARD, RACHEL KNEEN, MING LIM, NIGEL OSBORNE, JULIA RANKIN, NEIL STOODLEY, MARJO VAN DER KNAAP, ANDREA WHITNEY, PHILIP JARDINE. (2012) Childhood presentation of COL4A1 mutations. Developmental Medicine & Child Neurologyno-no
CrossRef3
Markus Sällman Almén, Josefin A. Jacobsson, George Moschonis, Christian Benedict, George P. Chrousos, Robert Fredriksson, Helgi B. Schiöth. (2012) Genome Wide Analysis Reveals Association of a FTO Gene Variant with Epigenetic Changes. Genomics
CrossRef4
Marion Jeanne, Cassandre Labelle-Dumais, Jeff Jorgensen, W. Berkeley Kauffman, Grazia M. Mancini, Jack Favor, Valerie Valant, Steven M. Greenberg, Jonathan Rosand, Douglas B. Gould. (2012) COL4A2 Mutations Impair COL4A1 and COL4A2 Secretion and Cause Hemorrhagic Stroke. The American Journal of Human Genetics 90:1, 91-101
CrossRef5
Peter Greaves. 2012. Cardiovascular System. , 263-324.
CrossRef6
Yuriko Yoneda, Kazuhiro Haginoya, Hiroshi Arai, Shigeo Yamaoka, Yoshinori Tsurusaki, Hiroshi Doi, Noriko Miyake, Kenji Yokochi, Hitoshi Osaka, Mitsuhiro Kato, Naomichi Matsumoto, Hirotomo Saitsu. (2011) De Novo and Inherited Mutations in COL4A2, Encoding the Type IV Collagen α2 Chain Cause Porencephaly. The American Journal of Human Genetics
CrossRef7
Kim M. Baeten, Katerina Akassoglou. (2011) Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke. Developmental Neurobiology 71:11, 1018-1039
CrossRef8
H. S. Markus. (2011) Stroke genetics. Human Molecular Genetics 20:R2, R124-R131
CrossRef9
Yongyi Bai, Liang Wang, Lan Sun, Ping Ye, Rutai Hui. (2011) Circulating microRNA-26a: Potential predictors and therapeutic targets for non-hypertensive intracerebral hemorrhage. Medical Hypotheses 77:4, 488-490
CrossRef10
Ildikó Kelemen-Valkony, Márton Kiss, Judit Csiha, András Kiss, Urs Bircher, János Szidonya, Péter Maróy, Gábor Juhász, Orbán Komonyi, Katalin Csiszár, Mátyás Mink. (2011) Drosophila basement membrane collagen col4a1 mutations cause severe myopathy. Matrix Biology
CrossRef11
Muhammad Bayu Sasongko, Tien Yin Wong, Kim C. Donaghue, Ning Cheung, Alicia J. Jenkins, Paul Benitez-Aguirre, Jie Jin Wang. (2011) Retinal Arteriolar Tortuosity is Associated With Retinopathy and Early Kidney Dysfunction in Type 1 Diabetes. American Journal of Ophthalmology
CrossRef12
M. B. Sasongko, T. Y. Wong, T. T. Nguyen, C. Y. Cheung, J. E. Shaw, J. J. Wang. (2011) Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy. Diabetologia 54:9, 2409-2416
CrossRef13
Jeffrey H. Miner. (2011) Glomerular basement membrane composition and the filtration barrier. Pediatric Nephrology 26:9, 1413-1417
CrossRef14
Linda M. Reis, Elena V. Semina. (2011) Genetics of anterior segment dysgenesis disorders. Current Opinion in Ophthalmology 22:5, 314-324
CrossRef15
Navdeep Sangha, Nicole R. Gonzales. (2011) Treatment Targets in Intracerebral Hemorrhage. Neurotherapeutics 8:3, 374-387
CrossRef16
J. F. Arboleda-Velasquez, J. Manent, J. H. Lee, S. Tikka, C. Ospina, C. R. Vanderburg, M. P. Frosch, M. Rodriguez-Falcon, J. Villen, S. Gygi, F. Lopera, H. Kalimo, M. A. Moskowitz, C. Ayata, A. Louvi, S. Artavanis-Tsakonas. (2011) PNAS Plus: Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease. Proceedings of the National Academy of Sciences 108:21, E128-E135
CrossRef17
Kenji Saito, Tomoko Yonezawa, Jun Minaguchi, Masae Kurosaki, Shiho Suetsugu, Ai Nakajima, Hiroyuki Nomoto, Yuki Morizane, Yoshikazu Sado, Manabu Sugimoto, Shozo Kusachi, Yoshifumi Ninomiya. (2011) Distribution of α(IV) collagen chains in the ocular anterior segments of adult mice. Connective Tissue Research 52:2, 147-156
CrossRef18
S. Alamowitch. (2011) Nouveaux syndromes génétiques responsables de vasculopathie cérébrale. Pratique Neurologique - FMC 2:2, 83-93
CrossRef19
Y. Yamamoto, L. Craggs, M. Baumann, H. Kalimo, R. N. Kalaria. (2011) Review: Molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathology and Applied Neurobiology 37:1, 94-113
CrossRef20
Katayoun Vahedi, Sonia Alamowitch. (2011) Clinical spectrum of type IV collagen (COL4A1) mutations: a novel genetic multisystem disease. Current Opinion in Neurology 24:1, 63-68
CrossRef21
Ryosuke Tsunematsu, Tomoko Shinozaki, Kotaro Fukushima, Yasuo Yumoto, Nobuhiro Hidaka, Seiichi Morokuma, Yasuyuki Fujita, Satoshi Hojo, Norio Wake. (2011) Congenital Abdominal Aortic Aneurysm with Porencephaly: A Case Report. Fetal Diagnosis and Therapy 29:3, 248-252
CrossRef22
Olivier M. Vanakker, Dimitri Hemelsoet, Anne De Paepe. (2011) Hereditary Connective Tissue Diseases in Young Adult Stroke: A Comprehensive Synthesis. Stroke Research and Treatment 2011, 1-18
CrossRef23
Osamu Onodera. (2011) What is cerebral small vessel disease?. Rinsho Shinkeigaku 51:6, 399-405
CrossRef24
Virginie Carmignac, Madeleine Durbeej. (2011) Cell-matrix interactions in muscle disease. The Journal of Pathologyn/a-n/a
CrossRef25
Gregory J. del Zoppo, Gerhard F. Hamann. 2011. The Cerebral Microvasculature and Responses to Ischemia. , 16-28.
CrossRef26
James F. Meschia, Daniel Woo. 2011. Stroke Genetics. , 268-278.
CrossRef27
E. Bernd Ringelstein, Ilka Kleffner, Ralf Dittrich, Gregor Kuhlenbäumer, Martin A. Ritter. (2010) Hereditary and non-hereditary microangiopathies in the young. An up-date. Journal of the Neurological Sciences 299:1-2, 81-85
CrossRef28
Jia Liu, Ben-Bo Gao, Edward P. Feener. (2010) Proteomic Identification of Novel Plasma Kallikrein Substrates in the Astrocyte Secretome. Translational Stroke Research 1:4, 276-286
CrossRef29
Ganeshwaran H. Mochida, Vijay S. Ganesh, Jillian M. Felie, Danielle Gleason, R. Sean Hill, Katie Rose Clapham, Daniel Rakiec, Wen-Hann Tan, Nadia Akawi, Muna Al-Saffar, Jennifer N. Partlow, Sigrid Tinschert, A. James Barkovich, Bassam Ali, Lihadh Al-Gazali, Christopher A. Walsh. (2010) A Homozygous Mutation in the Tight-Junction Protein JAM3 Causes Hemorrhagic Destruction of the Brain, Subependymal Calcification, and Congenital Cataracts. The American Journal of Human Genetics 87:6, 882-889
CrossRef30
C. E. Kashtan, Y. Segal, F. Flinter, D. Makanjuola, J.-S. Gan, T. Watnick. (2010) Aortic abnormalities in males with Alport syndrome. Nephrology Dialysis Transplantation 25:11, 3554-3560
CrossRef31
Karsten grosse Kreymborg, Shizuka Uchida, Pascal Gellert, André Schneider, Thomas Boettger, Robert Voswinckel, Astrid Wietelmann, Marten Szibor, Norbert Weissmann, Ardeschir Hossein Ghofrani, Ralph Schermuly, Dietmar Schranz, Werner Seeger, Thomas Braun. (2010) Identification of right heart-enriched genes in a murine model of chronic outflow tract obstruction. Journal of Molecular and Cellular Cardiology 49:4, 598-605
CrossRef32
Emmanuelle Plaisier, Zhiyong Chen, Florian Gekeler, Safa Benhassine, Karine Dahan, Béatrice Marro, Sonia Alamowitch, Michel Paques, Pierre Ronco. (2010) Novel COL4A1 mutations associated with HANAC syndrome: A role for the triple helical CB3[IV] domain. American Journal of Medical Genetics Part A 152A:10, 2550-2555
CrossRef33
Enrico Floßmann. 2010. Molecular Genetics of Ischaemic Stroke. .
CrossRef34
T. Van Agtmael, M. A. Bailey, U. Schlotzer-Schrehardt, E. Craigie, I. J. Jackson, D. G. Brownstein, I. L. Megson, J. J. Mullins. (2010) Col4a1 mutation in mice causes defects in vascular function and low blood pressure associated with reduced red blood cell volume. Human Molecular Genetics 19:6, 1119-1128
CrossRef35
Siddharth Shah, Yadlapalli Kumar, Brendan McLean, Amanda Churchill, Neil Stoodley, Julia Rankin, Patrizia Rizzu, Marjo van der Knaap, Philip Jardine. (2010) A dominantly inherited mutation in collagen IV A1 (COL4A1) causing childhood onset stroke without porencephaly. European Journal of Paediatric Neurology 14:2, 182-187
CrossRef36
Tom Van Agtmael, Leena Bruckner-Tuderman. (2010) Basement membranes and human disease. Cell and Tissue Research 339:1, 167-188
CrossRef37
R. Vanacore, A.-J. L. Ham, M. Voehler, C. R. Sanders, T. P. Conrads, T. D. Veenstra, K. B. Sharpless, P. E. Dawson, B. G. Hudson. (2009) A Sulfilimine Bond Identified in Collagen IV. Science 325:5945, 1230-1234
CrossRef38
AH Stam, J Haan, AMJM van den Maagdenberg, MD Ferrari, GM Terwindt. (2009) Migraine and genetic and acquired vasculopathies. Cephalalgia 29:9, 1006-1017
CrossRef39
Hara, Kenju, Shiga, Atsushi, Fukutake, Toshio, Nozaki, Hiroaki, Miyashita, Akinori, Yokoseki, Akio, Kawata, Hirotoshi, Koyama, Akihide, Arima, Kunimasa, Takahashi, Toshiaki, Ikeda, Mari, Shiota, Hiroshi, Tamura, Masato, Shimoe, Yutaka, Hirayama, Mikio, Arisato, Takayo, Yanagawa, Sohei, Tanaka, Akira, Nakano, Imaharu, Ikeda, Shu-ichi, Yoshida, Yutaka, Yamamoto, Tadashi, Ikeuchi, Takeshi, Kuwano, Ryozo, Nishizawa, Masatoyo, Tsuji, Shoji, Onodera, Osamu, . (2009) Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel Disease. New England Journal of Medicine 360:17, 1729-1739
Full Text40
Cabot, Richard C.Harris, Nancy Lee, Shepard, Jo-Anne O., Rosenberg, Eric S., Cort, Alice M., Ebeling, Sally H.Peters, Christine C., Brass, Steven D., Smith, Eric E., Arboleda-Velasquez, Joseph F., Copen, William A., Frosch, Matthew P., . (2009) Case 12-2009. New England Journal of Medicine 360:16, 1656-1665
Full Text41
Martien J.H. Kas, Cigdem Gelegen, Leonard C. Schalkwyk, David A. Collier. (2009) Interspecies comparisons of functional genetic variations and their implications in neuropsychiatry. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150B:3, 309-317
CrossRef42
Fiona E. Harrison, James M. May. (2009) Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radical Biology and Medicine 46:6, 719-730
CrossRef43
Joanna M. Wardlaw, Fergus Doubal, Paul Armitage, Francesca Chappell, Trevor Carpenter, Susana Muñoz Maniega, Andrew Farrall, Cathie Sudlow, Martin Dennis, Baljean Dhillon. (2009) Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Annals of Neurology 65:2, 194-202
CrossRef44
Linda S. de Vries, Corine Koopman, Floris Groenendaal, Mary Van Schooneveld, Frans W. Verheijen, Elly Verbeek, Theo D. Witkamp, H. Bart van der Worp, Grazia Mancini. (2009) COL4A1 mutation in two preterm siblings with antenatal onset of parenchymal hemorrhage. Annals of Neurology 65:1, 12-18
CrossRef45
Manuele Mine, Elisabeth Tournier-Lasserve. (2009) Intracerebral hemorrhage and COL4A1 mutations, from preterm infants to adult patients. Annals of Neurology 65:1, 1-2
CrossRef46
Heather J. McCrea, Laura R. Ment. (2008) The Diagnosis, Management, and Postnatal Prevention of Intraventricular Hemorrhage in the Preterm Neonate. Clinics in Perinatology 35:4, 777-792
CrossRef47
Atticus H Hainsworth, Hugh S Markus. (2008) Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. Journal of Cerebral Blood Flow & Metabolism 28:12, 1877-1891
CrossRef48
Andrew A. Mallick, Vijeya Ganesan. (2008) Arterial ischemic stroke in children - Recent advances. The Indian Journal of Pediatrics 75:11, 1149-1157
CrossRef49
Sophie Domingues-Montanari, Maite Mendioroz, Alberto del Rio-Espinola, Israel Fernández-Cadenas, Joan Montaner. (2008) Genetics of stroke: a review of recent advances. Expert Review of Molecular Diagnostics 8:4, 495-513
CrossRef50
KRJ Vanmolkot, GM Terwindt, RR Frants, J Haan, AMJM van den Maagdenberg, MD Ferrari. (2008) A gene for a new monogenic neurovascular migraine syndrome: a next step in unravelling molecular pathways for migraine?. Cephalalgia 28:5, 471-473
CrossRef51
Odile Boespflug-Tanguy, Pierre Labauge, Anne Fogli, Catherine Vaurs-Barriere. (2008) Genes involved in leukodystrophies: A glance at glial functions. Current Neurology and Neuroscience Reports 8:3, 217-229
CrossRef52
Chelsea S Kidwell, Max Wintermark. (2008) Imaging of intracranial haemorrhage. The Lancet Neurology 7:3, 256-267
CrossRef53
Plaisier, Emmanuelle, Gribouval, Olivier, Alamowitch, Sonia, Mougenot, Béatrice, Prost, Catherine, Verpont, Marie Christine, Marro, Béatrice, Desmettre, Thomas, Cohen, Salomon Yves, Roullet, Etienne, Dracon, Michel, Fardeau, Michel, Van Agtmael, Tom, Kerjaschki, Dontscho, Antignac, Corinne, Ronco, Pierre, . (2007) COL4A1 Mutations and Hereditary Angiopathy, Nephropathy, Aneurysms, and Muscle Cramps. New England Journal of Medicine 357:26, 2687-2695
Full Text54
Chen Xu Wang, Ashfaq Shuaib. (2007) Critical role of microvasculature basal lamina in ischemic brain injury. Progress in Neurobiology 83:3, 140-148
CrossRef55
Lorenzo Pasquali, Massimo Trucco, Steven Ringquist. (2007) Navigating pathways affecting type 1 diabetic kidney disease. Pediatric Diabetes 8:5, 307-322
CrossRef56
Igor Sibon, Isabelle Coupry, Patrice Menegon, Jean-Pierre Bouchet, Philippe Gorry, Ingrid Burgelin, Patrick Calvas, Isabelle Orignac, Vincent Dousset, Didier Lacombe, Jean-Marc Orgogozo, Benoît Arveiler, Cyril Goizet. (2007) COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke. Annals of Neurology 62:2, 177-184
CrossRef57
Michael A. Fox, Joshua R. Sanes, Dorin-Bogdan Borza, Veraragavan P. Eswarakumar, Reinhard Fässler, Billy G. Hudson, Simon W.M. John, Yoshifumi Ninomiya, Vadim Pedchenko, Samuel L. Pfaff, Michelle N. Rheault, Yoshikazu Sado, Yoav Segal, Michael J. Werle, Hisashi Umemori. (2007) Distinct Target-Derived Signals Organize Formation, Maturation, and Maintenance of Motor Nerve Terminals. Cell 129:1, 179-193
CrossRef58
M.C. Fernández Moreno, L. Castilla Guerra, J.M. Aguilera Navarro, M.D. Jiménez Hernández. (2007) Hemorragia intracerebral. Medicine - Programa de Formación Médica Continuada Acreditado 9:73, 4647-4655
CrossRef59
L. Castilla Guerra, M.D. Jiménez Hernández, M.C. Fernández Moreno, F. Moniche. (2007) Prevención del infarto cerebral. Medidas en prevención primaria y secundaria. Medicine - Programa de Formación Médica Continuada Acreditado 9:72, 4614-4622
CrossRef60
Cristina Has, Leena Bruckner-Tuderman. (2006) Molecular and diagnostic aspects of genetic skin fragility. Journal of Dermatological Science 44:3, 129-144
CrossRef61
Junichiro Hashimoto, Michael F OʼRourke. (2006) C-reactive protein and cardiovascular disease: are we looking in the right direction?. Journal of Hypertension 24:10, 2115
CrossRef62
Enrico Flossmann. (2006) Genetics of ischaemic stroke; single gene disorders. International Journal of Stroke 1:3, 131-139
CrossRef63
(2006) Mutations in COL4A1 might increase risk of hemorrhagic stroke. Nature Clinical Practice Neurology 2:7, 349-349
CrossRef64
Greenberg, Steven M., . (2006) Small Vessels, Big Problems. New England Journal of Medicine 354:14, 1451-1453
Full Text
